Literature DB >> 17576525

Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity.

Ludwika Kreja1, Astrid Liedert, Carla Schmidt, Lutz Claes, Anita Ignatius.   

Abstract

Human osteoclast (OC) formation and activity was studied in cultures of peripheral blood mononuclear cells (PBMNC) from six healthy donors after stimulation with fetal calf serum (FCS), under the influence of the receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) and the macrophage-colony stimulating factor (M-CSF). The results showed that selected FCS could stimulate OC formation without any medium supplementation with osteoclastogenic factors. The OC formation, investigated by quantification of multinucleated tartrate-resistant acid phosphatase-positive cells (TRAP+ cells), and the sensitivity of OC progenitors to RANKL and M-CSF, varied widely between individual donors. The OC resorption activity, measured in the "pit-assay" on dentine, was strictly dependent on the presence of RANKL and M-CSF in the medium and was also donor dependent. The considerable donor variability should be considered in culture studies investigating, e.g. the interactions of OC with biomaterials or the influence of cytokines, growth factors and drugs on osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576525     DOI: 10.1007/s10735-007-9108-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  12 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Human osteoclast culture from peripheral blood monocytes: phenotypic characterization and quantitation of resorption.

Authors:  Katherine A Buckley; Benjamin Y Y Chan; William D Fraser; James A Gallagher
Journal:  Methods Mol Med       Date:  2005

Review 3.  Modulation of osteoclast formation.

Authors:  Julian M W Quinn; Matthew T Gillespie
Journal:  Biochem Biophys Res Commun       Date:  2005-03-18       Impact factor: 3.575

4.  Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL).

Authors:  G C Nicholson; M Malakellis; F M Collier; P U Cameron; W R Holloway; T J Gough; C Gregorio-King; M A Kirkland; D E Myers
Journal:  Clin Sci (Lond)       Date:  2000-08       Impact factor: 6.124

5.  The human osteoclast precursor circulates in the monocyte fraction.

Authors:  Y Fujikawa; J M Quinn; A Sabokbar; J O McGee; N A Athanasou
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

6.  Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors.

Authors:  J Faust; D L Lacey; P Hunt; T L Burgess; S Scully; G Van; A Eli; Y Qian; V Shalhoub
Journal:  J Cell Biochem       Date:  1999-01-01       Impact factor: 4.429

7.  Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.

Authors:  M Husheem; J K E Nyman; J Vääräniemi; H K Vaananen; T A Hentunen
Journal:  Calcif Tissue Int       Date:  2005-02-07       Impact factor: 4.333

8.  Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Authors:  Gerald J Atkins; Panagiota Kostakis; Katie J Welldon; Cristina Vincent; David M Findlay; Andrew C W Zannettino
Journal:  J Cell Physiol       Date:  2005-06       Impact factor: 6.384

9.  Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.

Authors:  Jason M Hodge; Mark A Kirkland; Cathy J Aitken; Caryll M Waugh; Damian E Myers; Carolina M Lopez; Brendan E Adams; Geoffrey C Nicholson
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

10.  Resorbability of bone substitute biomaterials by human osteoclasts.

Authors:  Arndt F Schilling; Wolfgang Linhart; Sandra Filke; Matthias Gebauer; Thorsten Schinke; Johannes M Rueger; Michael Amling
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

View more
  5 in total

1.  The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro.

Authors:  Anita Ignatius; Christian Ehrnthaller; Rolf E Brenner; Ludwika Kreja; Philipp Schoengraf; Patricia Lisson; Robert Blakytny; Stefan Recknagel; Lutz Claes; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  J Trauma       Date:  2011-10

2.  Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.

Authors:  Anita Ignatius; Philipp Schoengraf; Ludwika Kreja; Astrid Liedert; Stefan Recknagel; Sebastian Kandert; Rolf E Brenner; Marion Schneider; John D Lambris; Markus Huber-Lang
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

3.  Gingipains promote RANKL-induced osteoclastogenesis through the enhancement of integrin β3 in RAW264.7 cells.

Authors:  Weiyan Mo; Haoyuan Luo; Juan Wu; Na Xu; Fuping Zhang; Qihong Qiu; Wenjun Zhu; Min Liang
Journal:  J Mol Histol       Date:  2020-03-19       Impact factor: 2.611

4.  Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways.

Authors:  Yu Yuan; Kai Chen; Xi Chen; Chao Wang; Heng Qiu; Zhen Cao; Dezhi Song; Youqiang Sun; Jianmin Guo; Jennifer Tickner; Jiake Xu; Jun Zou
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

5.  Triple Culture of Primary Human Osteoblasts, Osteoclasts and Osteocytes as an In Vitro Bone Model.

Authors:  Anne Bernhardt; Jasmin Skottke; Max von Witzleben; Michael Gelinsky
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.